Shane Hostetter Purchases 3,350 Shares of Chemours (NYSE:CC) Stock

The Chemours Company (NYSE:CC) CFO Shane Hostetter acquired 3,350 shares of Chemours stock in a transaction on Thursday, August 6th. The shares were bought at an average cost of $14.94 per share, with a total value of $50,049.00. Following the completion of the transaction, the chief financial officer owned 102,698 shares of the company’s stock, valued at approximately $1,534,308.12. This trade represents a 3.37% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Chemours Price Performance

Shares of CC opened at $14.82 on Wednesday. The firm has a market capitalization of $2.23 billion, a PE ratio of -7.76 and a beta of 1.43. The company’s 50-day moving average is $18.91 and its 200-day moving average is $20.04. The Chemours Company has a fifty-two week low of $10.44 and a fifty-two week high of $28.67. The company has a debt-to-equity ratio of 18.98, a current ratio of 1.66 and a quick ratio of 0.88.

Chemours (NYSE:CC) last announced its earnings results on Tuesday, August 4th. The specialty chemicals company reported $0.42 EPS for the quarter, missing the consensus estimate of $0.49 by ($0.07). Chemours had a positive return on equity of 60.64% and a negative net margin of 5.00%.The company had revenue of $1.59 billion for the quarter, compared to the consensus estimate of $1.65 billion. During the same period in the previous year, the firm posted ($2.54) EPS. The business’s quarterly revenue was down 1.5% on a year-over-year basis. Equities analysts forecast that The Chemours Company will post 0.91 EPS for the current year.

Chemours Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Friday, August 14th will be given a dividend of $0.0875 per share. The ex-dividend date is Friday, August 14th. This represents a $0.35 annualized dividend and a yield of 2.4%. Chemours’s dividend payout ratio (DPR) is -18.32%.

Institutional Investors Weigh In On Chemours

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Atlas Capital Advisors Inc. acquired a new stake in Chemours during the fourth quarter worth approximately $26,000. Aster Capital Management DIFC Ltd acquired a new position in Chemours in the 4th quarter valued at $28,000. Allworth Financial LP bought a new stake in shares of Chemours during the 2nd quarter valued at $51,000. Covestor Ltd grew its holdings in shares of Chemours by 204.7% during the 4th quarter. Covestor Ltd now owns 2,602 shares of the specialty chemicals company’s stock worth $31,000 after purchasing an additional 1,748 shares in the last quarter. Finally, Eurizon Capital SGR S.p.A. acquired a new stake in shares of Chemours during the 4th quarter worth $31,000. 76.26% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

CC has been the topic of a number of recent research reports. Morgan Stanley set a $18.00 target price on Chemours in a research note on Monday. Weiss Ratings downgraded Chemours from a “sell (d)” rating to a “sell (d-)” rating in a research note on Thursday, August 6th. Royal Bank Of Canada decreased their price objective on Chemours from $26.00 to $22.00 and set an “outperform” rating on the stock in a report on Thursday, August 6th. Truist Financial lowered their price objective on Chemours from $30.00 to $24.00 and set a “buy” rating on the stock in a research report on Thursday, August 6th. Finally, Mizuho set a $22.00 target price on Chemours in a report on Wednesday, August 5th. One investment analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $21.00.

Chemours Company Profile

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.